Literature DB >> 33969130

Para-Clinical and Immunological Evaluation in Buerger's Disease as a Suspected Autoimmune Disease: Case Series.

Abbas Shapouri-Moghaddam1, Seyed Jalil Tavakkol Afshari1, Hamid Reza Rahimi2, Mohammad-Hadi Saeed Modaghegh3, Mahmoud Mahmoudi1, Seyed Morteza Ehteshamfar1.   

Abstract

BACKGROUND: Autoimmunity causes the loss of normal immune homeostasis and involves the presence of autoantibodies and inflammation. Thromboangiitis obliterans or Buerger's disease (BD) refers to a type of vascular obstructive syndrome, with tobacco exposure accounting for disease formation and progression. However, the current understanding of autoimmunity is unclear in the context of BD, and the scientific findings are not enough to support autoimmune mechanisms. This study was aimed at investigating autoimmunity factors in patients with BD.
METHODS: Clinical and experimental examinations were performed on 80 patients with BD. The diagnostic work-up for autoimmunity was composed of IgM rheumatoid factor (RF), anti-nuclear antibodies (ANA), The erythrocyte sedimentation rate (ESR), anti-cyclic citrullinated peptide (CCP) antibodies, Antiphospholipid antibodies (APA), Anti-cardiolipin antibodies (ACLA), anti-double-stranded DNA (ds-DNA), and extractable nuclear antigen (ENA) profile. Immunomarkers were detected using the quantitative enzyme-linked immunosorbent assay (ELISA).
RESULTS: Raynaud's phenomenon (84.93%), cold sensitivity (76.25%), and claudication (73.75%) were the most common symptoms in the BD patients. Also, 64.29% represented with high ANA levels and positive RF, while 42.11% were found with increased ANA and ESR levels. The ANA/RF positive BD patients had ESR> 15 mm/hr and a high prevalence of cold sensitivity, claudication, and Raynaud's phenomenon (p> 0.05).
CONCLUSION: There is a possibility of a non-specific autoimmune disposition among BD patients. RF and ANA could be considered for predicting disease progression.

Entities:  

Keywords:  Antibodies; Autoimmunity; Buerger's Disease; Immune System

Year:  2021        PMID: 33969130      PMCID: PMC8068440          DOI: 10.52547/rbmb.9.4.373

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  24 in total

Review 1.  Erythrocyte sedimentation rate and C-reactive protein.

Authors:  Michael Harrison
Journal:  Aust Prescr       Date:  2015-06-01

Review 2.  The canonical Notch signaling pathway: unfolding the activation mechanism.

Authors:  Raphael Kopan; Maria Xenia G Ilagan
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

Review 3.  Buerger disease (thromboangiitis obliterans).

Authors:  Ian Del Conde; Constantino Peña
Journal:  Tech Vasc Interv Radiol       Date:  2014-11-13

Review 4.  Intestinal involvement in Buerger's disease.

Authors:  Z Hassoun; M Lacrosse; T De Ronde
Journal:  J Clin Gastroenterol       Date:  2001-01       Impact factor: 3.062

Review 5.  Autoimmune diseases in the intensive care unit. An update.

Authors:  Olga L Quintero; Adriana Rojas-Villarraga; Ruben D Mantilla; Juan-Manuel Anaya
Journal:  Autoimmun Rev       Date:  2012-06-25       Impact factor: 9.754

6.  Humoral and cellular immune response to Buerger's disease.

Authors:  Seyed Morteza Ehteshamfar; Jalil Tavakkol Afshari; Mohammad-Hadi S Modaghegh; Mahmoud Mahmoudi; Gholam Hosein Kazemzadeh; Fatemeh Sadeghipour Kermani
Journal:  Vascular       Date:  2020-03-25       Impact factor: 1.285

7.  Smoking characteristics and cessation in patients with thromboangiitis obliterans.

Authors:  C A Jiménez-Ruiz; L C Dale; J Astray Mochales; L Velázquez Buendía; I de Granda Orive; A Guirao García
Journal:  Monaldi Arch Chest Dis       Date:  2006-12

Review 8.  Effects of tobacco smoke on immunity, inflammation and autoimmunity.

Authors:  Yoav Arnson; Yehuda Shoenfeld; Howard Amital
Journal:  J Autoimmun       Date:  2009-12-29       Impact factor: 7.094

9.  Laboratory Studies in Autoimmune Diseases.

Authors:  Terry L Moore; Austin M Dalrymple
Journal:  Mo Med       Date:  2016 Mar-Apr

10.  The Association of HLA-A, B and DRB1 with Buerger's Disease.

Authors:  Abbas Shapouri-Moghaddam; Mojgan Mohammadi; Hamid Reza Rahimi; Habibolah Esmaeili; Mahmoud Mahmoudi; Mohammad-Hadi Saeed Modaghegh; Jalil Tavakol Afshari
Journal:  Rep Biochem Mol Biol       Date:  2019-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.